286 Arch Dis Child: first published as 10.1136/adc.2003.048447 on 20 February 2004. Downloaded from ARCHIMEDES Towards evidence based medicine for paediatricians Edited by Bob Phillips ............................................................................................................................... Arch Dis Child 2004;89:286–290. doi: 10.1136/adc.2003.048280 n order to give the best care to patients and families, Beyond the evidence paediatricians need to integrate the highest quality scientific evidence with clinical expertise and the opinions It would be a wonderful thing if every treatment we used had I 1 of the family. Archimedes seeks to assist practising clinicians been tested in trials where the populations matched ours by providing ‘‘evidence based’’ answers to common questions exactly. Sadly, this isn’t the case. In paediatrics, the evidence which are not at the forefront of research but are at the core we have may be in the ‘‘wrong’’ population: including lots of of practice. In doing this, we are adapting a format which has adults or children of the wrong age. Or the outcomes been successfully developed by Kevin Macaway-Jones and recorded may only be surrogates, rather than clinically the group at the Emergency Medicine Journal—‘‘BestBets’’. important changes. In order to use the best evidence in A word of warning. The topic summaries are not systematic practice, we need to consider how far we can take the results ‘‘beyond the evidence’’. reviews, through they are as exhaustive as a practising Fortunately, as with many aspects of critical appraisal, clinician can produce. They make no attempt to statistically there are guides as to how to think about the issues related to aggregate the data, nor search the grey, unpublished 1 using studies which don’t directly apply to our population. It literature. What Archimedes offers are practical, best evidence is suggested that first, we should ask if there are biological based answers to practical, clinical questions. differences between the populations. For example, does the The format of Archimedes may be familiar. A description of same process produce cradle cap in babies as seborrhoeic the clinical setting is followed by a structured clinical dermatitis in adults? Here it may be relevant to look at question. (These aid in focusing the mind, assisting search- pathological data, or compare the results of studies of ing,2 and gaining answers.3) A brief report of the search used alternative treatments in the populations under suspicion. follows—this has been performed in a hierarchical way, to Second, it is appropriate to consider whether differences in search for the best quality evidence to answer the question.4 psychology, social setting, or economy will stop the data A table provides a summary of the evidence and key points of being applicable. When we turn to psychological differences the critical appraisal. For further information on critical it is clearly inappropriate to use a cognitive-behavioural appraisal, and the measures of effect (such as number needed therapy in infants, but how should we appraise a trial which to treat, NNT) books by Sackett5 and Moyer6 may help. To shows improved quality of life in adults? If there are pull the information together, a commentary is provided. But significant differences in economic or social setting, it may strongly affect the family’s adherence to a therapy. to make it all much more accessible, a box provides the http://adc.bmj.com/ If the treatment seems to be feasible and sensible, we are clinical bottom lines. suggested to address issues of risk and co-morbidity. If The electronic edition of this journal contains extra COX-2 inhibitors do reduce the chance of gastrointestinal information to each of the published Archimedes topics. The bleeding,2 should we be using them in children with juvenile papers summarised in tables are linked, by an interactive arthritis? We need to know the basic risk of GI bleeding in table, to more detailed appraisals of the studies. Updates to our population, in order to estimate the benefit they may gain previously published topics will be linked to the original from using the new drugs. article when they are available. This month an electronic The last issue to consider is that of outcomes. What is the on September 30, 2021 by guest. Protected copyright. update on ‘‘Inhaled steroids in the treatment of mild to information on side effects? Is there any information about moderate persistent asthma in children once or twice daily adverse events in children? Are the outcomes we are given administration’’ has been published. directly relevant to our patients (such as improved function in Readers wishing to submit their own questions—with best JIA) or surrogate outcomes (such as reduced serum CRP)? evidence answers—are encouraged to review those already As with everything in evidence based practice, these proposed at www.bestbets.org. If your question still hasn’t guides don’t give you the rules to act on, but tools to think been answered, feel free to submit your summary according through. When considering if you can go ‘‘beyond the evidence’’, look at biological and psychological differences, to the Instructions for Authors at www.archdischild.com. consider the inherent risk and co-morbidities, and examine Three topics are covered in this issue of the journal. all the outcomes closely. Then you’ll have a better idea of N Should we screen every child with otitis media with how far you can apply ‘‘best evidence’’ to your practice. effusion for allergic rhinitis? N Should we treat infantile seborrhoeic dermatitis with topical antifungals or topical steroids? References N Is routine EEG helpful in the management of complex 1 Dans A, Mcallister F, Dans A, et al. Applying results to individual patients. febrile seizures? Chapter 2–3. In: Guyatt & Rennie, eds. Users’ guides to the medical literature. American Medical Association, 2002. 2 Deeks JJ, Smith LA, Bradley MD. Efficacy, tolerability, and upper Bob Phillips, Evidence-based On Call, Centre for Evidence- gastrointestinal safety of celecoxib for treatment of osteoarthritis and based Medicine, University Dept of Psychiatry, Warneford rheumatoid arthritis: systematic review of randomised controlled trials. BMJ Hospital, Headington OX3 7JX, UK; 2002;325:619. [email protected] www.archdischild.com Archimedes 287 Arch Dis Child: first published as 10.1136/adc.2003.048447 on 20 February 2004. Downloaded from REFERENCES believed that Spiro had OME because he suffered from 1 Moyer VA, Ellior EJ. Preface. In: Moyer VA, Elliott EJ, Davis RL, et al, eds. allergic rhinitis (AR). Should we look for AR in every child Evidence based pediatrics and child health, Issue 1. London: BMJ Books, 2000. with OME? 2 Richardson WS, Wilson MC, Nishikawa J, et al. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995;123:A12–13. 3 Bergus GR, Randall CS, Sinift SD, et al. Does the structure of clinical questions affect the outcome of curbside consultations with specialty colleagues? Arch Structured clinical question Fam Med 2000;9:541–7. Do children with OME [population] have an increased risk of 4 http://cebm.jr2.ox.ac.uk/docs/levels.htm (accessed July 2002). 5 Sackett DL, Starus S, Richardson WS, et al. Evidence-based medicine. How to AR [outcome] than children without OME [comparison]? practice and teach EBM. San Diego: Harcourt-Brace, 2000. 6 Moyer VA, Elliott EJ, Davis RL, et al, eds. Evidence based pediatrics and child health, Issue 1. London: BMJ Books, 2000. Search strategy and outcome Our search strategy (extended to 2 August 2003) was: N Cochrane Database of Systematic Reviews using: ‘‘otitis Additional information on each of the topics is media AND allergy’’; 13 references (none relevant). available on the ADC website (www.archdischild. com/supplemental) N Medline, via Pubmed: ‘‘otitis media with effusion AND allergic rhinitis’’; 62 references (four relevant). See table 1. Commentary Should we screen every child with The full text of two relevant studies34was not accessible to us (one was published in Japanese, the other in Turkish); otitis media with effusion for however, the abstract furnished sufficient details for a allergic rhinitis? summary evaluation of their validity and utility for our question. Report by The studies that we examined in full text12showed S Miceli Sopo, Department of Pediatrics, Catholic marked difference in the prevalence of AR in children with OME: 16.3% versus 89%. Trying to explain this discrepancy, it University of Rome, Italy; can be noted that the study of Alles and colleagues2 is affected [email protected] by some methodological imperfections that seriously compro- G Zorzi, Department of Pediatrics, Catholic mise its validity. It lacks a well defined control group and the study definitions of AR and OME are weak. For AR, neither the University of Rome, Italy appearance of the symptoms after exposure to an allergen nor M jr Calvani, Department of Paediatrics, San the demonstration, necessarily, of sensitisation to an allergen Camillo De Lellis Hospital, Rome, Italy through measurement of the specific IgE is required. Even the definition of OME was not strong: an unconfirmed history of doi: 10.1136/adc.2003.048041 OME was sufficient for enrolment. The prevalence of the AR in children with OME in the study of Caffarelli and colleagues1 piro, a 12 year old boy, was referred to the Allergy gives the more reliable estimates; because of the fact that their Clinic of Department of Pediatrics because of otitis study is prospective, and the authors have adopted rigorous media with effusion (OME) that had been present diagnostic criteria for both the illness studied (AR and OME), S http://adc.bmj.com/ for the past four years. A paediatrician and an otolaryngol- have included an adequate control population, and have ogist advised a consultation with an allergist because they enrolled a sufficient number of children.